Search

Your search keyword '"Grandval, Philippe"' showing total 199 results

Search Constraints

Start Over You searched for: Author "Grandval, Philippe" Remove constraint Author: "Grandval, Philippe"
199 results on '"Grandval, Philippe"'

Search Results

1. Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study)

2. Classification of PRSS1 variants responsible for chronic pancreatitis: An expert perspective from the Franco-Chinese GREPAN Study Group

3. Insuffisance intestinale aiguë et réinstillation de chyme.

7. Classification of PRSS1 variants responsible for chronic pancreatitis: An expert perspective from the Franco-Chinese GREPAN Study Group

9. Endoscopic resection of early esophageal tumors in the context of cirrhosis or portal hypertension: a multicenter observational study

10. Risk factors for endoscopic ultrasound-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study)

11. Endoscopic resection of early esophageal tumors in patients with cirrhosis or portal hypertension: a multicenter observational study.

12. Identification of protease-sensitive but not misfolding PNLIP variants in familial and hereditary pancreatitis

13. Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts

14. Relevance of biopsy-derived pancreatic organoids in the development of efficient transcriptomic signatures to predict adjuvant chemosensitivity in pancreatic cancer

19. Evaluation of the performances of a single‐use duodenoscope: Prospective multi‐center national study

21. Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer

26. Performance of digital single-operator cholangiopancreatoscope for biliopancreatic diseases in real life: results from a prospective multicenter study

27. Abstract CT236: A phase 1b, multicenter, randomized, blinded, placebo-controlled study to evaluate the efficacy of guselkumab in subjects with familial adenomatous polyposis

29. EUS-guided choledochoduodenostomy by use of electrocautery-enhanced lumen-apposing metal stents: a French multicenter study after implementation of the technique (with video)

30. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes

31. Evaluation of the performances of a single‐use duodenoscope: Prospective multi‐center national study.

37. Genomic profile concordance between pancreatic cyst fluid and neoplastic tissue

38. Traitement endoscopique de l'atteinte duodénale au cours de la polypose adénomateuse familiale.

39. 19 G nitinol needle versus 22 G needle for transduodenal endoscopic ultrasound-guided sampling of pancreatic solid masses: a randomized study

40. Endoscopic ultrasound-guided choledochoduodenostomy with electrocautery-enhanced lumen-apposing stents: a retrospective analysis

41. Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes

42. Efficacy and safety of pasireotide-LAR for the treatment of refractory bleeding due to gastrointestinal angiodysplasias: results of the ANGIOPAS multicenter phase II noncomparative prospective double-blinded randomized study

43. Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts

44. Abstract 4396: Multiomics assessment of the cancer and stromal compartments of patient-derived pancreatic xenografts reveals clinically-relevant subtypes and novel targeted therapies

45. Novel therapeutic targets for pancreatic adenocarcinoma revealed by a multi-omics analysis of patient-derived xenografts

46. Double Guidewire Endoscopic Technique, a Major Evolution in Endoscopic Retrograde Cholangiopancreatography: Results of a Retrospective Study with Historical Controls Comparing Two Therapeutic Sequential Strategies

47. Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ 1: implications for individualized medicine efforts

48. Human pancreatic lipase-related protein 2 is a galactolipase

49. Abstract A48: Multi-omics characterization of PDAC subtypes using PDX reveals that epigenetic but not genetic analysis permit a clinically relevant classification

50. Abstract B72: Pancreatic cancer cell drives stroma composition

Catalog

Books, media, physical & digital resources